BANKA BIOLOO
|
BANKA BIOLOO Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -0.60 | 2.34 | 2.87 | 2.14 | 15.14 |
| CEPS(Rs) | 1.40 | 3.71 | 3.73 | 2.73 | 6.51 |
| DPS(Rs) | - | - | - | - | 1.00 |
| Book NAV/Share(Rs) | 36.50 | 36.97 | 34.57 | 29.21 | 68.16 |
| Tax Rate(%) | -19.14 | 29.94 | 6.08 | -18.01 | 20.64 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 6.30 | 12.70 | 12.43 | 9.67 | 15.78 |
| EBIT Margin(%) | 3.37 | 11.11 | 11.40 | 9.60 | 15.76 |
| Pre Tax Margin(%) | -0.96 | 7.43 | 7.40 | 5.24 | 14.25 |
| PAT Margin (%) | -1.15 | 5.21 | 6.95 | 6.18 | 11.31 |
| Cash Profit Margin (%) | 2.59 | 8.25 | 9.05 | 7.86 | 12.16 |
| Performance Ratios | |||||
| ROA(%) | -0.94 | 3.93 | 5.63 | 4.73 | 13.31 |
| ROE(%) | -1.68 | 6.54 | 9.20 | 7.60 | 22.22 |
| ROCE(%) | 3.30 | 9.94 | 10.80 | 8.55 | 21.98 |
| Asset Turnover(x) | 0.82 | 0.75 | 0.81 | 0.77 | 1.18 |
| Sales/Fixed Asset(x) | 3.01 | 3.64 | 4.75 | 5.26 | 10.06 |
| Working Capital/Sales(x) | 2.44 | 1.70 | 1.26 | 1.33 | 2.31 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.33 | 0.27 | 0.21 | 0.19 | 0.10 |
| Receivable days | 142.92 | 162.06 | 130.71 | 136.35 | 99.26 |
| Inventory Days | 70.23 | 103.67 | 87.46 | 60.34 | 24.95 |
| Payable days | 79.50 | 224.24 | 166.89 | 272.33 | 132.86 |
| Valuation Parameters | |||||
| PER(x) | - | 29.78 | 28.50 | 27.86 | 1.55 |
| PCE(x) | 66.68 | 18.80 | 21.87 | 21.92 | 3.60 |
| Price/Book(x) | 2.56 | 1.89 | 2.36 | 2.05 | 0.86 |
| Yield(%) | - | - | - | - | 1.71 |
| EV/Net Sales(x) | 2.47 | 2.08 | 2.60 | 2.15 | 0.65 |
| EV/Core EBITDA(x) | 29.46 | 12.77 | 16.73 | 16.28 | 3.41 |
| EV/EBIT(x) | 62.41 | 16.25 | 19.73 | 19.13 | 3.60 |
| EV/CE(x) | 1.91 | 1.60 | 1.57 | 1.41 | 0.67 |
| M Cap / Sales | 2.02 | 1.79 | 2.29 | 2.02 | 0.50 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 18.06 | 9.29 | 27.23 | -36.37 | - |
| Core EBITDA Growth(%) | -39.29 | 14.64 | 49.44 | -55.98 | - |
| EBIT Growth(%) | -63.54 | 6.25 | 48.88 | -60.52 | - |
| PAT Growth(%) | -126.43 | -18.30 | 40.95 | -64.59 | - |
| EPS Growth(%) | -125.70 | -18.30 | 33.60 | -85.84 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.63 | 0.37 | 0.44 | 0.35 | 0.41 |
| Current Ratio(x) | 1.95 | 2.56 | 3.07 | 3.92 | 3.22 |
| Quick Ratio(x) | 1.62 | 1.78 | 2.28 | 3.04 | 2.87 |
| Interest Cover(x) | 0.78 | 3.02 | 2.85 | 2.20 | 10.46 |
| Total Debt/Mcap(x) | 0.24 | 0.20 | 0.18 | 0.17 | 0.47 |
Compare Financial Ratios of peers of BANKA BIOLOO
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BANKA BIOLOO | ₹109.0 Cr | 0.6% | -4.6% | 43.3% | Stock Analytics | |
| LARSEN & TOUBRO | ₹492,620.0 Cr | -0.6% | -2.4% | 4.4% | Stock Analytics | |
| RAIL VIKAS NIGAM | ₹85,298.2 Cr | -1.8% | -3.2% | 141.8% | Stock Analytics | |
| GMR AIRPORTS INFRASTRUCTURE | ₹81,642.0 Cr | 0.5% | -3.3% | 5.9% | Stock Analytics | |
| IRB INFRASTRUCTURE DEVELOPERS | ₹33,595.0 Cr | 0% | 5.6% | 34.2% | Stock Analytics | |
| IRCON INTERNATIONAL | ₹19,699.1 Cr | -4% | -0.9% | 24.5% | Stock Analytics | |
BANKA BIOLOO Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BANKA BIOLOO | 0.6% |
-4.6% |
43.3% |
| SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses
